Business Description
Mangoceuticals Inc
NAICS : 923120
SIC : 7372
ISIN : US56270V1061
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.05 | |||||
Beneish M-Score | 33.91 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.21 | |||||
9-Day RSI | 51.93 | |||||
14-Day RSI | 49.91 | |||||
6-1 Month Momentum % | -46.46 | |||||
12-1 Month Momentum % | -39.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 19.25 | |||||
Days Payable | 646.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -8.94 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.75 | |||||
Operating Margin % | -1175.46 | |||||
Net Margin % | -1236.87 | |||||
FCF Margin % | -720.42 | |||||
ROE % | -164.24 | |||||
ROA % | -141.4 | |||||
ROIC % | -143.44 | |||||
ROC (Joel Greenblatt) % | -5365.01 | |||||
ROCE % | -154.8 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.17 | |||||
PB Ratio | 0.4 | |||||
EV-to-EBIT | -0.72 | |||||
EV-to-EBITDA | -0.72 | |||||
EV-to-Revenue | 8.44 | |||||
EV-to-FCF | -1.17 | |||||
Earnings Yield (Greenblatt) % | -138.89 | |||||
FCF Yield % | -86.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MGRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mangoceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.754 | ||
EPS (TTM) ($) | -5.71 | ||
Beta | 0 | ||
Volatility % | 124.23 | ||
14-Day RSI | 49.91 | ||
14-Day ATR ($) | 0.17416 | ||
20-Day SMA ($) | 2.508745 | ||
12-1 Month Momentum % | -39.08 | ||
52-Week Range ($) | 2.1 - 16.799999 | ||
Shares Outstanding (Mil) | 2.49 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mangoceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mangoceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Mangoceuticals Inc Frequently Asked Questions
What is Mangoceuticals Inc(MGRX)'s stock price today?
When is next earnings date of Mangoceuticals Inc(MGRX)?
Does Mangoceuticals Inc(MGRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |